Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)

被引：0

作者：

Xiang Zhang

Lotte C. A. Stiekema

Erik S. G. Stroes

Albert K. Groen

机构：

[1] Amsterdam University Medical Center,Department of Experimental Vascular Medicine

[2] University of Amsterdam,Human and Animal Physiology

[3] Wageningen University,Department of Vascular Medicine

[4] Amsterdam University Medical Center,undefined

[5] University of Amsterdam,undefined

来源：

Lipids in Health and Disease | / 19卷

关键词：

PCSK9 antibodies; Evolocumab; Lipoprotein(a); Metabolomics; VLDL;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用